Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis

Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis

Background: The association of patient and prescriber characteristics with use of warfarin versus direct-acting oral anticoagulants (DOACs) in patients with atrial fibrillation (AF) and chronic kidney disease (CKD) is not well studied. Methods: The 20% Centers for Medicare & Medicaid Services Pa...

Full description

Bibliographic Details
Main Authors:	Jorge L. Reyes MD, Charles A. Herzog MD, Heng Yan MS, Nicholas S. Roetker PhD, James B. Wetmore MD, MS
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-12-01
Series:	Journal of Cardiovascular Pharmacology and Therapeutics
Online Access:	https://doi.org/10.1177/10742484221142220

Similar Items

Prescribing and Safety of Direct-Acting Oral Anticoagulants Compared to Warfarin in Patients with Atrial Fibrillation on Chronic Hemodialysis
by: Estella Davis, et al.
Published: (2020-03-01)

Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery
by: Dannick Brochu PharmD, et al.
Published: (2022-09-01)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
by: Tracey G. Simon, et al.
Published: (2023-02-01)

Retrospective Comparison of Patients ≥ 80 Years With Atrial Fibrillation Prescribed Either an FDA-Approved Reduced or Full Dose Direct-Acting Oral Anticoagulant
by: Roy Taoutel, et al.
Published: (2022-12-01)

Prescribing patterns of new oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: A narrative review
by: O. Chernatska
Published: (2023-09-01)

Pattern of oral anticoagulant prescribing for atrial fibrillation in general practice: an observational study in The Netherlands
by: Catharina CM Kager, et al.
Published: (2023-03-01)

New Insights into Anticoagulation in Atrial Fibrillation
by: Xiaohan Fan, MD, et al.
Published: (2011-01-01)

Oral Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: Mihai Ciprian Stoica, et al.
Published: (2021-04-01)

Identifying prescribing differences of direct oral anticoagulants for atrial fibrillation within the Military Health System
by: William Hirschfeld, et al.
Published: (2023-02-01)

Effectiveness and Safety of Direct Oral Anticoagulants in Thai Patients with Atrial Fibrillation: A Real-World Retrospective Cohort Study
by: Saowaluk Srikajornlarp MD, et al.
Published: (2022-10-01)

Problem of prescribing anticoagulant therapy in patients with atrial fibrillation on the regional level
by: M. G. Nazarkina, et al.
Published: (2020-08-01)

Use of Direct‐Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Significant Tricuspid Regurgitation
by: Yujin Yang, et al.
Published: (2024-02-01)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
by: Matej Samoš, et al.
Published: (2022-10-01)

Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: V. I. Petrov, et al.
Published: (2019-09-01)

Kidney Function and the Use of Vitamin K Antagonists or Direct Oral Anticoagulants in Atrial Fibrillation
by: Gencheva Dolina
Published: (2023-09-01)

NEW ORAL ANTICOAGULANTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE
by: E. P. Panchenko
Published: (2015-12-01)

Exploring clinician perspectives on patients with atrial fibrillation who are not prescribed anticoagulation therapy
by: Catherine Yao, et al.
Published: (2022-12-01)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
by: Eric Duong, BSc, MSc, PharmD, et al.
Published: (2023-08-01)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
by: Roberto Galea, et al.
Published: (2023-09-01)

Oral anticoagulant therapy for older patients with atrial fibrillation
by: Mario Bo, et al.
Published: (2017-09-01)

An Updated Pooled Analysis of Off-Label Under and Over-Dosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation
by: Nan-Nan Shen MS, et al.
Published: (2023-06-01)

Oral Anticoagulation in Patients with Chronic Kidney Disease and Non-Valvular Atrial Fibrillation: The FAERC Study
by: Marco Montomoli, et al.
Published: (2022-12-01)

Anticoagulant Treatment in Patients with Atrial Fibrillation and Chronic Kidney Disease
by: Marta Popović, et al.
Published: (2021-01-01)

Specifics of anticoagulation in combination with atrial fibrillation and chronic kidney disease
by: N. Sh. Zagidullin, et al.
Published: (2021-10-01)

Left atrial thrombosis in patients with atrial fibrillation during uninterrupted oral anticoagulation
by: Boyan Kunev, et al.
Published: (2021-10-01)

Gender Differences in Patients with Atrial Fibrillation Receiving Oral Anticoagulants
by: Jo-Nan Liao, et al.
Published: (2024-03-01)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Renal Dysfunction
by: Z. D. Kobalava, et al.
Published: (2021-03-01)

Oral anticoagulants and atrial fibrillation: A South African perspective
by: D LaÃ¤s, et al.
Published: (2018-07-01)

Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
by: Paula Tiili, et al.
Published: (2021-01-01)

Oral Anticoagulant Discontinuation and Its Predictors in Patients with Atrial Fibrillation
by: Adane Teshome Kefale, et al.
Published: (2022-10-01)

Association of Depression and Adherence to Oral Anticoagulation in Patients With Atrial Fibrillation
by: Matthew E. Lapa, et al.
Published: (2023-11-01)

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
by: Maria Cristina Vedovati, et al.
Published: (2022-08-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Atrial Fibrillation in Kidney Failure: Challenges in Risk Assessment and Anticoagulation Management
by: Mandy M. Law, et al.
Published: (2023-09-01)

Prescribing Trends of Oral Anticoagulants from 2010 to 2020 in Shanghai, China: A Retrospective Study
by: Chi Zhang MM, et al.
Published: (2022-10-01)

NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION
by: Ju. P. Skirdenko, et al.
Published: (2018-03-01)

The use of oral anticoagulants in patients with atrial fibrillation: cohort study data
by: O. V. Gaisenok, et al.
Published: (2016-09-01)

Old and new oral anticoagulants for secondary stroke prevention in atrial fibrillation
by: Tommaso Sacquegna, et al.
Published: (2015-12-01)

Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?
by: Stefan Naydenov, et al.
Published: (2021-05-01)

Vascular Protective Effects of New Oral Anticoagulants in Patients with Atrial Fibrillation
by: Gyeong-Won Jang, et al.
Published: (2021-09-01)